TWI PHARMACEUTICALS INC has a total of 22 patent applications. Its first patent ever was published in 2011. It filed its patents most often in China, Taiwan and Australia. Its main competitors in its focus markets pharmaceuticals are GIONAS S R L, AXOVANT SCIENCES LTD and AGA NANOTECH LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | China | 3 | |
#2 | Taiwan | 3 | |
#3 | Australia | 2 | |
#4 | Canada | 2 | |
#5 | EPO (European Patent Office) | 2 | |
#6 | Republic of Korea | 2 | |
#7 | United States | 2 | |
#8 | WIPO (World Intellectual Property Organization) | 2 | |
#9 | Argentina | 1 | |
#10 | Brazil | 1 | |
#11 | Mexico | 1 | |
#12 | Singapore | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Medical preparations |
# | Name | Total Patents |
---|---|---|
#1 | Lee Shao-Ming | 10 |
#2 | Jan Chaur-Ming | 10 |
#3 | Lu Guang-Wei | 8 |
#4 | Kao Yu-Han | 7 |
#5 | Chen Chou-Hsiung | 7 |
#6 | Liao Shih-Fen | 7 |
#7 | Chen Shou-Chiung | 7 |
#8 | Chen Chih-Ming | 7 |
#9 | Chen Yu-Yin | 7 |
#10 | Liaw Ling-Ying | 7 |
Publication | Filing date | Title |
---|---|---|
AU2019213835A1 | Topical formulations comprising tofacitinib | |
US2015209292A1 | Controlled release formulations and preparation method thereof | |
WO2011163206A2 | Controlled release compositions with reduced food effect |